3
Announcements
Trials
Browse
Landscape
Status
Completed
6
Terminated
3
Withdrawn
1
No longer available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Small Cell Lung Carcinoma
1
Interventions
ceritinib
2
tazemetostat
1
taletrectinib
1
sotorasib
1
rovalpituzumab tesirine
1
rociletinib
1
pegilodecakin
1
patritumab deruxtecan
1
osimertinib
1
lorlatinib
1
dabrafenib
1
capmatinib
1
brigatinib
1
belagenpumatucel L
1
alectinib
1
Suspensions
1
Powders
1
Paclitaxel
1
Nivolumab
1
Crizotinib
1
BID protein, human
1
AM0010
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
No longer available
×
rovalpituzumab tesirine
×
Thoracic
×
Clear all
NCT03503890
2019-09-10
Expanded Access to Rovalpituzumab Tesirine
AbbVie
No longer available